Long-term effect of additional tiotropium bromide on pulmonary function in patients with severe chronic asthma Source: Annual Congress 2006 - Recent advances in the treatment of asthma and allergic rhinitis Year: 2006
Long-term efficacy of twice-daily aclidinium bromide in COPD patients: A one-year study Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot study Source: Eur Respir J, 49 (6) 1700485; 10.1183/13993003.00485-2017 Year: 2017
Effects of twice-daily aclidinium bromide in COPD patients: A long-term extension of ACCORD-COPD I Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Effect of tiotropium bromide as an additional therapy in severe intractable asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 49s Year: 2005
Comparative study of one-year treatment with salmeterol along, and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructi e pulmonary diseases (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
The role of tiotropium bromide in physical training for patients with COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
Effect of treatment with tiotropium bromide 18 mcg on asthma control and asthma-related quality of life in patients with asthma-COPD overlap syndrome. Source: International Congress 2017 – Techniques to treat asthma Year: 2017
Influence of tiotropium bromide on quantity of exacerbations and survival rate of COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007
Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Ensifentrine added on to tiotropium significantly improves lung function, symptoms and QoL in symptomatic COPD patients regardless of baseline reversibility Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study Source: Eur Respir J 2007; 30: Suppl. 51, 34s Year: 2007
Long-term safety of twice-daily aclidinium bromide in COPD patients: A one-year, double-blind study Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Aclidinium bromide improves resting lung function in patients with moderate to severe COPD Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Correlates of quality of life in COPD outpatients. Preliminary results from the PRE-SPIRO survey Source: Annual Congress 2008 - COPD epidemiology Year: 2008
Six months treatment with salmeterol or ipratropium bromide improves effort tolerance and reduces dyspnoea but does not have any effect on lung function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 108s Year: 2002
The effect of pulmonary rehabilitation on exercise tolerance and quality of life in patients with COPD. Preliminary data Source: Eur Respir J 2001; 18: Suppl. 33, 223s Year: 2001
Comparative study of two years treatment with salmeterol alone and in combination with ipratropium bromide and beclometazone dipropionate in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Long-term effect of sildenafil on exercise capacity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 608s Year: 2007